TIMP2 and triple-negative breast carcinoma: The N-TIMP2 variant (either WT or REY) was added to the cells at different concentrations, ranging from 100 to 600 nM, as this range of concentrations has been shown to be effective in various assays on triple-negative breast cancer cells [39] (see Methods).